Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

215P - Assessment of patient and clinician awareness and clinical outcomes of changes in lifestyle habits during lung cancer treatment


31 Mar 2023


Poster Display session


Ana Isabel Martin Quesada


Journal of Hepatology (2023) 18 (4S): S154-S159.


A.I. Martin Quesada1, M.G. Gordo2, P.R. Hernaez2, A. Herrero Márquez2, L. Herrera GorrÍn3, A. Cardena2, C. Dorta Pérez2, M.L. Soriano Tabares4, C. Hernandez Perez2, M. Morales-Gonzalez2

Author affiliations

  • 1 Santa Cruz de Tenerife/ES
  • 2 Hospital Universitario Nuestra Senora de Candelaria, Santa Cruz de Tenerife/ES
  • 3 Universidad de La Laguna, San Cristobal de la Laguna/ES
  • 4 Hospital Universitario Nuestra Senora de Candelaria, 38010 - Santa Cruz de Tenerife/ES


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 215P


Exercise and eating habits play a fundamental role in patients with lung cancer, having an impact on mortality, duration of hospitalizations, post-surgical complications, sarcopenia, quality of life and even in overall survival. There are studies which also show how physical exercise can improve the response to immunotherapy. However, we are unaware of the lifestyle habits of our patients, a knowledge gap in our therapeutic approach which we seek to address with this study.


Cross-sectional observational study featuring patients diagnosed with lung cancer at the Medical Oncology Service of the Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife. We tested the statistical significance of lifestyle habit changes as measured by a form and IPAQ, MUST, and SARC-F surveys using chi-squared tests.


We involved 43 patients with a mean age of 65 years. 84% had stage-four cancer, 77% were receiving first-line treatment and 60% were being treated with immunotherapy. 100% of individuals considered their diet as an important pillar in their cancer disease. However, we found that only 50% had discussed aspects of their nutrition with their oncologist. 77% considered that a healthy lifestyle could help reduce the adverse effects of the treatment, and 21% did not know whether it could help. The validated test results showed that 56% had an intermediate-high risk of malnutrition according to the MUST test and 19% had risk of sarcopenia according to the SARC-F test. Patients receiving treatment via immunotherapy or targeted therapy had a lower risk of malnutrition than those receiving other treatments (43.8% vs 63%), although this result did not reach statistical significance (p = 0.220). 49% were sedentary according to the IPAQ test and 83% who did not perform physical activity would start an adapted exercise program if it were available.


The results show that most patients have a general awareness about the importance of the lifestyle during treatment, and the need to invest time and resources to improve their clinical outcomes. However, they could benefit from more clarity about the specific nutritional and fitness initiatives they could undertake, and their ranked impact on their health.

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.